Atticus Wealth Management’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-250
Closed -$3.94K 282
2025
Q2
$3.94K Hold
250
﹤0.01% 535
2025
Q1
$3.17K Hold
250
﹤0.01% 438
2024
Q4
$5.5K Hold
250
﹤0.01% 426
2024
Q3
$4.46K Sell
250
-900
-78% -$14.4K ﹤0.01% 434
2024
Q2
$18.5K Hold
1,150
0.01% 320
2024
Q1
$17.1K Hold
1,150
0.01% 343
2023
Q4
$20.6K Hold
1,150
0.01% 329
2023
Q3
$22K Buy
1,150
+650
+130% +$11.3K 0.01% 329
2023
Q2
$7.93K Buy
+500
New +$8.23K ﹤0.01% 419

Other funds holding CLMT

Atticus Wealth Management's CLMT Position: Q3 2025 in Review

Atticus Wealth Management sold out of Calumet Specialty Products (CLMT) in Q3 2025, closing a stake of 250 shares — an estimated $3.94K sold.

Atticus Wealth Management first reported a position in CLMT in Q2 2023 and held it in 9 quarters. The position peaked at $22K in Q3 2023. 149 funds tracked by Wall St. Rank hold CLMT as of Q3 2025.

  • Atticus Wealth Management reported no remaining Calumet Specialty Products position as of Q3 2025 after selling out during the quarter.
  • Atticus Wealth Management sold 250 Calumet Specialty Products shares in Q3 2025, an estimated $3.94K.
  • Atticus Wealth Management first reported a position in Calumet Specialty Products in Q2 2023 and held it in 9 quarters.
  • Atticus Wealth Management's Calumet Specialty Products position peaked at $22K in Q3 2023.
  • 149 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2025.

Based on Atticus Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.